Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide

Radiology

Volumn 244, Issue 1, 2007, Pages 196-204

  Haider, Masoom A ^a   Davidson, Sean R H ^b   Kale, Ashwini V ^a   Weersink, Robert A ^b   Evans, Andrew J ^a   Toi, Ants ^a   Gertner, Mark R ^b   Bogaards, Arjen ^b   Wilson, Brian C ^b   Chin, Joseph L ^c   Elhilali, Mostafa ^d   Trachtenberg, John ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; GADOLINIUM PENTETATE; PALLADIUM BACTERIOPHEOPHORBIDE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BONE MARROW; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTRAST ENHANCEMENT; EXTERNAL BEAM RADIOTHERAPY; HUMAN; LEVATOR ANI MUSCLE; MALE; NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CARCINOMA; PUBIC BONE; RECURRENT CANCER; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; BACTERIOCHLOROPHYLLS; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; PHOTOCHEMOTHERAPY; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 34250807251     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2441060398     Document Type: Article

References (27)

1. Nichol A, Chung P, Lockwood G, et al. A phase II study of localized prostate cancer treated to 75.6 Gy with 3D conformal radiotherapy. Radiother Oncol 2003;76:11-17.
2. Zietman AL, DeSilvio ML, Slater JD, et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 2003; 294:1233-1239.
3. Pollack A, Zagars GK, Antolak JA, Kuban DA, Rosen II. Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial. Int. J Radiat Oncol Biol Phys 2002;54:677-685.
4. Zelefsky MJ, Leibel SA, Gaudin PB, et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998;41:491-500.
5. Crook JM, Bahadur YA, Bociek RG, Perry GA, Robertson SJ, Esche BA. Radiotherapy for localized prostate carcinoma: the correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen. Cancer 1997;79:328-336.
6. Lee WR, Hanks GE, Hanlon A. Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observations. J Clin Oncol 1997;15:230-238.
7. Bianco FJ Jr, Scardino PT, Stephenson AJ, Diblasio CJ, Fearn PA, Eastham JA. Long-term oncologic results of salvage radical prostatectomy for locally recurrent, prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys 2005;62:448-453.
8. Ward JF, Sebo TJ, Blute ML, Zincke H. Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes. J Urol 2005;173:1156-1160.
9. Izawa JI, Perrotte P, Greene GF, et al. Local tumor control with salvage cryotherapy for locally recurrent prostate cancer after external beam radiotherapy. J Urol 2001;165: 867-870.
10. Chin JL, Pautler SF, Mouraviev V, Touma N, Moore K, Downey DR. Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol 2001;165:1937-1941.
11. Chen JC, Moriarty JA, Derbyshire JA, et al. Prostate cancer: MR imaging and thermometry during microwave thermal ablation-initial experience. Radiology 2000;214:290-297.
12. Ackroyd R, Kelly C, Brown N, Reed M. The history of photodetection and photodynamic therapy. Photochem Photobiol 2001;74: 656-669.
13. Radu A, Wagnieres G, van den Bergh H, Monnier P. Photodynamic therapy of early squamous cell cancel's of the esophagus. Gastrointest Endosc Clin N Am 2000;10: 439-460.
14. Metz JM, Friedberg JS. Endobronchial photodynamic therapy for the treatment of lung cancer. Chest Surg Clin N Am 2001;11:829-839.
15. Jichlinski P, Leisinger HJ. Photodynamic therapy in superficial bladder cancer: past, present and future. Urol Res 2001;29:396-405.
16. Chen Q, Huang Z, Luck D, et al. Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancers. Photochem Photobiol 2002;76:438-445.
17. Borle F, Radu A, Fontolliet C, van den Bergh II, Mourner P, Wagnieres G. Selectivity of the photosensitiser Tookad for photodynamic therapy evaluated in the Syrian golden hamster cheek pouch tumour model. Br J Cancer 2003;89:2320-2326.
18. Gross S, Gilead A, Scherz A, Neeman M, Salomon Y. Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI. Nat Med 2003;9:1327-1331.
19. Kelleher DK, Thews O, Scherz A, Salomon Y, Vaupel P. Perfusion, oxygenation status and growth of experimental tumors upon photodynamic therapy with Pd-bacteriopheophorbide. Int J Oncol 2004;24:1505-1511.
20. Borle F, Radu A, Monnier P, van den Bergh H, Wagnieres G. Evaluation of the photosensitizer Tookad for photodynamic therapy on the Syrian golden hamster cheek pouch model: light dose, drug dose and drug-light interval effects. Photochem Photobiol 2003; 78:377-383.
21. Huang Z, Haider MA, Kraft S, et al. Magnetic resonance imaging correlated with the histopathological effect of Pd-bacteriopheophorbide (Tookad) photodynamic therapy on the normal canine prostate gland. Lasers Surg Med 2006;38:672-681.
22. Moore CM, Nathan TR, Lees WR, et al. Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer. Lasers Surg Med 2006;38:356-363.
23. Weersink RA, Bogaards A, Gertner M, et al. Techniques for delivery and monitoring of TOOKAD (WST09)-mediated photodynamic therapy of the prostate: clinical experience and practicalities. J Photochem Photobiol B 2003;79:211-222.
24. Sherar MD, Gertner MR, Yue CK, et al. Interstitial microwave thermal therapy for prostate cancer: method of treatment and results of a phase I/II trial. J Urol 2001;166: 1707-1714.
25. Zou KH, Tuncali K, Silverman SG. Correlation and simple linear regression. Radiology 2003;227:617-622.
26. Huang Z, Chen Q, Trucic N, et al. Effects of Pd-bacteriopheophorbide (TOOKAD)-mediated photodynamic therapy on canine prostate pretreated with ionizing radiation. Radiat Res 2004;161:723-731.
27. Sheaff MT, Baithun SI. Effects of radiation on the normal prostate gland. Histopathology 1997;30:341-348.